Recent progress in vaccines against foot-and-mouth disease

• Autorzy: Niedbalski W. , Fitzner A. , Bulenger K.
• Języki publikacji: EN

Abstrakty

EN

Foot-and-mouth disease (FMD) is the most highly contagious disease affecting livestock resulting in a significant adverse economic impact worldwide. Disease outbreaks in previously FMD-free countries are initially controlled by the culling of infected and in-contact animals, restriction of susceptible animal movement, and vaccination with an inactivated whole-virus antigen preparation. With increasing trade, commerce globalization, and people migration, it is likely that more inter-pool viral exchanges and spillovers will occur posing a greater threat to both, endemic and non-endemic regions, mostly due to the limited antigenic coverage of current vaccines. Currently available inactivated FMD vaccines have a number of disadvantages, including incomplete inactivation of the virus, they require multiple vaccination to maintain good levels of immunity and periodic inclusion of new viral strains into the vaccine formulation to cover new FMDV subtypes against which existing vaccines no longer protect and lack differentiation of infected from vaccinated animals (DIVA). The essential aim of DIVA strategy is realization of the so-called “vaccinate-to-live” policy, which is based on the principles that vaccinated animals exposed to FMDV will not transmit the virus. To address the shortcomings of inactivated vaccines, many efforts are currently devoted to developing novel FMD vaccines, including attenuated and marker inactivated vaccines, recombinant protein vaccines, synthetic peptide vaccines and empty capsid vaccines. Novel vaccine platforms offer promising alternatives for effective FMD control. It is likely that in the near future, multiple FMD vaccine approaches will compete for diverse markets, providing fit-for purpose solutions to evolving challenges in preventing and controlling FMD worldwide.

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2019
• Tom: 75
• Numer: 09
• Opis fizyczny: p.528-533, fig.,ref.

Twórcy

autor

Niedbalski W.

• Department of Foot and Mouth Disease, National Veterinary Research Institute, Wodna 7, 98-220 Zdunska Wola, Poland

autor

Fitzner A.

• Department of Foot and Mouth Disease, National Veterinary Research Institute, Wodna 7, 98-220 Zdunska Wola, Poland

autor

Bulenger K.

• Department of Foot and Mouth Disease, National Veterinary Research Institute, Wodna 7, 98-220 Zdunska Wola, Poland

Bibliografia

• Arzt J., Pacheco J. M., Smoliga G. R., Tucker M. T., Bishop E., Pauszek S. J., Hartwig E. J., de los Santos T., Rodriguez L. L.: Foot-and-mouth disease virus virulence in cattle is co-determined by viral replication dynamics and route of infection. Virology 2014, 452-453, 12-22.
• Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J.: Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J. Immunol. 1975, 115, 1636-1641.
• Beard C., Ward G., Rieder E., Chinsangaram J., Grubman M. J., Mason P. W.: Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J. Biotechnol. 1999, 73, 243-249.
• Belsham G. J., Abrams C. C., King A. M., Roosien J., Vlak J. M.: Myristoylation of foot-and-mouth disease virus capsid protein precursors is independent of other viral proteins and occurs in both mammalian and insect cells. J. Gen. Virol. 1991, 72, 747-751.
• Berinstein A., Tami C., Taboga O., Smitsaart E., Carrillo E.: Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Vaccine 2000, 18, 2231-2238.
• Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F.: Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1982, 298, 30-33.
• Blanco E., Guerra B., de la Torre B. G., Defaus S., Dekker A., Andreu D., Sobrino F.: Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide. Antiviral Res. 2016, 129, 74-80.
• Cedillo-Barron L., Foster-Cuevas M., Belsham G. J., Lefevre F., Parkhouse R. M.: Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J. Gen. Virol. 2001, 82, 1713-1724.
• Chinsangaram J., Beard C., Mason P. W., Zellner M. K., Ward G., Grubman M. J.: Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J. Virol. 1998, 72, 4454-4457.
• Diaz-San Segundo F., Medina G. N., Ramirez-Medina E., Velazquez-Salinas L., Koster M., Grubman M. J., de los Santos T.: Synonymous deoptimization of foot-and-mouth disease virus causes attenuation in while inducing a strong neutralizing antibody response. J. Virol. 2015, 90, 1298-1310.
• Doel T. R.: FMD vaccines. Virus Res. 2003, 91, 81-99.
• Domingo E., Baranowski E., Escarmis C., Sobrino F.: Foot-and-mouth disease virus. Comp. Immunol. Microbiol. Infect. Dis. 2002, 25, 297-308.
• Fernandez-Sainz I., Medina G. N., Ramirez-Medina E., Koster M. J., Grubman M. J., de Los Santos T.: Adenovirus – vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine. Virology 2017, 502, 123-132.
• Fowler V. L., Bashiruddin J. B., Maree F. F., Mutowembwa P., Bankowski B., Gibson D., Cox S., Knowles N., Barnett P. V.: Foot-and-mouth disease marker vaccine: cattle protection with a partial VP1 G-H loop deleted virus antigen. Vaccine 2011, 29, 8405-8411.
• Ganges L., Borrego B., Fernandez-Pacheco P., Revilla C., Fernandez-Borges N., Dominguez J., Sobrino F., Rodriguez F.: DNA immunization of pigs with footand-mouth disease virus minigenes: from partial protection to disease exacerbation. Virus Res. 2011, 157, 121-125.
• Grubman M. J., Baxt B.: Foot-and-mouth disease. Clin. Microbiol. Rev. 2004, 17, 465-493.
• Grubman M. J., Lewis S. A., Morgan D. O.: Protection of swine against footand-mouth disease with viral capsid proteins expressed in heterologous systems. Vaccine 1993, 11, 825-829.
• Grubman M. J., Moraes M., Schutta C., Barrera J., Neilan J. G., Ettyreddy D., Butman B. T., Brough D. E., Brake D. A.: Adenovirus serotype 5-vectored footand-mouth disease subunit vaccines: the first decade. Future Virol. 2010, 5, 14.
• Gullberg M., Lohse L., Botner A., McInerney G. M., Burman A., Jackson T., Polacek C., Belsham G. J.: A prime-boost vaccination strategy in cattle to prevent foot-and-mouth disease using a single-cycle alphavirus vector and empty capsid particles. PLoS One 2017, 12, e0173327, doi. 10.1371/journal.pone.0173327.
• Gullberg M., Muszyński B., Organtini L. J., Ashley R. E., Hafenstein S. L., Belsham G. J., Polacek C.: Assembly and characterization of foot-and-mouth disease virus empty capsid particles expressed within mammalian cells. J. Gen. Virol. 2013, 94, 1769-1779.
• Li H., Li Z., Xie Y., Qin X., Qi X., Sun P., Bai X., Ma Y., Zhang Z.: Novel chimeric foot-and-mouth disease virus-like particles harbouring serotype O VP1 protect guinea pigs against challenge. Vet. Microbiol. 2016, 183, 92-96.
• Li P., Lu Z., Bai X., Li D., Sun P., Bao H., Fu Y., Cao Y., Chen Y., Xie B., Yin H., Liu Z.: Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine. Vet. Res. 2014, 45, 51, doi: 10.1186/1297-9716-45-51.
• Li Z., Yi Y., Yin X., Zhang Y., Liu M., Liu H., Li X., Li Y., Zhang Z., Liu J.: Development of foot-and-mouth disease virus serotype A empty capsid subunit vaccine using silkworm (Bombyx mori) pupae. PLoS One 2012, 7, e43849, doi:10.1371/journal.pone.0043849
• Lombard M., Fussel A. E.: Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination. Rev. Sci. Tech. 2007, 26, 117-134.
• Lombard M., Pastoret P. P., Moulin A. M.: A brief history of vaccines and vaccination. Rev. Sci. Tech. 2007, 26, 29-48.
• Ma M., Jin N., Shen G., Zhu G., Liu H. J., Zheng M., Lu H., Huo X., Jin M., Yin G., Ma H., Li X., Ji Y., Jin K.: Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18. Vet. Immunol. Immunopathol. 2008, 121, 1-7.
• Mason P. W., Piccone M. E., Mckenna T. S., Chinsangram J., Grubman M. J.: Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 1997, 227, 96-102.
• Mayr G. A., O’Donnell V., Chinsangram J., Mason P. W., Grubman M. J.: Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 2001, 19, 2152-2162.
• Medina G. N., Montiel N., Diaz-San Segundo F., Sturza D., Ramirez-Medina E., Grubman M. J., de los Santos T.: Evaluation of a fiber-modified adenovirus vector vaccine against foot-and-mouth disease in cattle. Clin. Vaccine Immunol. 2015, 23, 125-136.
• Mohana Subramanian B., Madhanmohan M., Sriraman R., Chandrasekhar Reddy R. V., Yuvaraj S., Manikumar K., Rajalakshmi S., Negendrakumar S. B., Rana S. K., Srinivasan V. A.: Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency. Antyviral Res. 2012, 96, 288-295.
• Nanda R. K., Hajam I. A., Edao B. M., Ramya K., Rajangam M., Chandra Sekar S., Ganesh K., Bhanuprakash V., Kishore S.: Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth virus DNA vaccine, pVAC FMDV VP1-OmpA in guinea pigs, Biologicals 2014, 42, 153-159.
• Ni Z., Yang F., Cao W., Zhang X., Jin Y., Mao R., Du X., Li W., Guo J., Liu X., Zhu Z., Zheng H.: Differential gene expression in porcine SK6 cells infected with wild-type and SAP domain-mutant foot-and-mouth disease virus. Virol. Sin. 2016, 31, 249-257.
• Niedbalski W., Fitzner A.: DIVA strategy in the eradication of foot-and-mouth disease. Med. Weter. 2017, 73, 23-27.
• Niedbalski W., Kęsy A.: Foot and mouth disease vaccine banks in Europe: present status and future prospects. Med. Weter. 2007, 63, 394-398.
• Niedbalski W., Wijaszka T., Kęsy A.: Marker vaccines – a new approach to controlling and eradicating foot and mouth disease. Med. Weter. 2003, 59, 279-282.
• OIE.: Terrestrial Animal Health Code. 2016, Chapter 8.8, Foot and mouth disease. Article 8.8.7., Recovery of free status.
• Pacheco J. M., Smoliga G. R., O’Donnell V., Brito B. P., Stenfeldt C., Rodriguez L. L., Arzt J.: Persistent foot-and-mouth disease virus infection in the nasopharynx of cattle: tissue-specific distribution and local cytokine expression. PLoS One 2015, 10, e0125698, doi: 10.1371/journal.pone.0125698.
• Parida S., Cox S. J., Reid S. M., Hamblin P., Barnett P. V., Inoue T., Anderson J., Paton D. J.: The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-andmouth disease. Vaccine 2005, 23, 5186-5195.
• Paton D. J., Valarcher J. F., Bergmann I., Matlho O. G., Zakharov V. M., Palma E. L., Thomson G. R.: Selection of foot and mouth disease vaccine strains – a review. Rev. Sci. Tech. 2005, 24, 981-993.
• Pena L., Moraes M. P., Koster M., Burrage T., Pacheco J. M., Segundo F. D., Grubman M. J.: Delivery of foot-and-mouth disease virus empty capsid subunit antigen with non-structural protein 2B improves protection of swine. Vaccine 2008, 26, 5689-5699.
• Pluimers F. H., Akkerman A. M., van der Wal P., Dekker A., Bianchi A.: Lessons from the foot and mouth disease outbreaks in the Netherlands in 2001. Rev. Sci. Tech. 2002, 21, 711-721.
• Rodriguez L. L., Grubman M. J.: Foot and mouth disease virus vaccines. Vaccine 2009, 27, D90-D94.
• Saiz J. C., Cairo J., Medina M., Zuidema D., Abrams C., Belsham G. J., Domingo E., Vlak J. M.: Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization. J. Virol. 1994, 68, 4557-4564.
• Segundo F. D., Weiss M., Perez-Martin E., Dias C. C., Grubman M. J., Santos T. de los: Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease. J. Virol. 2012, 86, 1316-1327.
• Shao J. J., Wang J. F., Chang H. Y., Liu J. X.: Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep. Virol. Sin. 2011, 26, 190-197.
• Soria I., Quattrocchi V., Langellotti C., Gammella M., Digiacomo S., Garcia de la Torre B., Andreu D., Montoya M., Sobrino F., Blanco E., Zamorano P.: Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle. PLos One 2017, 12, e0185184, doi: 10.1371/journal.pone.0185184.
• Stenfeldt C., Diaz-San Segundo F., de Los Santos T., Rodriguez L. L., Arzt J.: The pathogenesis of foot-and-mouth disease in pigs. Front Vet Sci. 2016, 3, 41, doi: 10.3389/fvets.2016.00041.
• Taboga O., Tami C., Carrillo E., Nunez J. I., Rodriguez A., Saiz J. C., Blanco E., Valero M. L., Roig X., Camarero J. A., Andreu D., Mateu M. G., Giralt E., Domingo E., Sobrino F., Palma E. L.: A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 1997, 71, 2606-2614.
• Uddowla S., Hollister J., Pacheco J. M., Rodriguez L. L., Rieder E.: A safe footand-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. J. Virol. 2012, 86, 11675-11685.
• Uddowla S., Pacheco J. M., Larson C., Bishop E., Rodriguez L. L., Rai D. K., Arzt J., Rieder E.: Characterization of a chimeric foot-and-mouth disease virus bearing a bovine rhinitis B virus leader proteinase. Virology 2013, 447, 172-180.
• Veerapen V. P., van Zyl A. R., Wigdorovitz A., Rybicki E. P., Meyers A. E.: Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana bethamiana. Virus Res. 2018, 244, 213-217.
• Wang C. Y., Chang T. Y., Walfield A. M., Ye J., Shen M., Chen S. P., Li M. C., Lin Y. L., Jong M. H., Yang P. C., Chyr N., Kramer E., Brown F.: Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 2002, 20, 2603-2610.
• Xiao Y., Chen H. Y., Wang Y., Yin B., Lv C., Mo X., Yan H., Xuan Y., Huang Y., Pang W., Li X., Yuan Y. A., Tian K.: Large-scale production of foot-and-mouth disease virus (serotype Asia 1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. BMC Biotechnol. 2016, 16, 56, doi: 10.1186/s12896-016-0285-6.
• Xin A., Zhu M., Peng Z., Hu Q., Shi C., Liao D., Wang J., Li H.: Genomic changes in an attenuated ZB strain of foot-and-mouth disease virus serotype Asia 1and comparison with its virulent parental strain. Int. J. Genomics 2014, 978609, doi: 10.1155/2014/978609.
• Zhang K., Huang J., Wang Q., He Y., Xu Z., Xiang M., Wu B., Chen H.: Recombinant pseudorabies virus expressing P12A and 3C of FMDV can partially protect piglets against FMDV challenge. Res. Vet. Sci. 2011, 91, 90-94.
• Zhang Z., Pan L., Ding Y., Zhou P., Lv J., Chen H., Fang Y., Liu X., Chang H., Zhang J., Shao J., Lin T., Zhao F., Zhang Y., Wang Y.: Efficacy of synthetic peptide candidate vaccines against serotype A foot-and-mouth disease virus in cattle. Appl. Microbiol. Biotechnol. 2015, 99, 1389-1398.
• Zheng M., Jin N., Zhang H., Jin M., Lu H., Ma M., Li C., Yin G., Wang R., Liu Q.: Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus. J. Virol. Methods 2006, 136, 230-237.

Identyfikatory

DOI

10.21521/mw.6212